Memory, attentional, and behavioural symptoms are the clinical hallmarks of Neurocognitive disorders (NCD) such as Alzheimer's disease and related disorders. The World Health Organisation (WHO) guidelines for risk reduction of cognitive decline and dementia indicate that Cognitive training may be offered to older adults with normal cognition and with mild cognitive impairment to reduce the risk of cognitive decline and/or dementia. The use of Information and Communication Technologies (ICT) in the health domain is progressively expanding. The Alzheimer Innovation Association have developed MeMo (Memory Motivation) a free web application that can be used at home by patients. The objective of the present study was to assess the effectiveness of employing the MeMo platform on cognitive performance in patients suffering from NCD.
The objective of this study is to evaluate the effectiveness of the MeMo cognitive training exercise platform in patients suffering from neurocognitive disorders. These exercises ,have been developed by the association Innovation Alzheimer and the CoBTeK research team, located with the Nice memory Center at the Institut Claude Pompidou. MeMo can be used freely at home by patients. More specifically, it is a randomized controlled study that aims to compare the evolution of activities cognition and behavior between patients not using these exercises, and patients using these exercises for 12 weeks, 4 sessions per week.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
49
The patient betwenn 2 consultation could use the application MeMo. MeMo is a web application that can thus be used on any web browser (computer or tablet). On tablet, the application can be installed on home screen to look like a native app, and used offline.
the patient have the classical follow up at the memory center (consultation)
CoBtek lab, Institut Claude Pompidou
Nice, France
Change is being assessed with the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE)
To score the IQCODE, add up the score for each question and divide by the number of questions. For the long IQCODE, divide by 26.
Time frame: Base line, Week 12
Change in attention is is being assessed with the DSST
Digit Symbol Substitution Test (attentional task)
Time frame: Base line, Week 12
Change in frontal functioning is being assessed with the FAB
the Frontal Assessment Battery: Score 0 (healthy) - 18 (pathology)
Time frame: Base line, Week 12
Change in behavior is being assessed with the NPI
Neuropsychiatric Inventory score 0 (healthy) - 134 (pathology)
Time frame: Base line, Week 12
IA-C
Change in motivation is being assessed with theApathy inventory, clinician version score 0 (healthy)- 12 (pathology)
Time frame: Base line, Week 12
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.